# Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer

> **NCT02945631** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 43 (actual)

## Conditions studied

- Locally Advanced HPV Positive Oropharynx Cancer

## Interventions

- **RADIATION:** PTV56
- **RADIATION:** PTV50.4

## Key facts

- **NCT ID:** NCT02945631
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-04-25
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02945631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02945631, "Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02945631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*